Skip to content

Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)

Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06485700
Acronym
PT4A
Enrollment
1140
Registered
2024-07-03
Start date
2025-11-18
Completion date
2028-04-20
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Hypertension

Brief summary

Peer-based medication delivery decreases the cost of transportation and the opportunity cost of travel while HIT can support peer activities by facilitating targeted adherence counseling, teleconsultation, synchronization of clinical care, and pharmacy activities. The investigators have implemented a pilot program of door-to-door peer-based medication delivery and HIT in western Kenya, and preliminary data indicate improved adherence and blood pressure. However, the effectiveness of this implementation strategy is not fully established. Therefore, the objective of the study is to use the PRECEDE-PROCEED framework to conduct transdisciplinary implementation research to test the hypothesis that integrating peer delivery of medications with HIT (PT4A) improves medication adherence and reduces blood pressure among patients with uncontrolled hypertension in western Kenya.

Detailed description

Aim 1 will evaluate the effectiveness of PT4A by conducting a two-arm cluster randomized controlled implementation research hybrid type 2 trial, comparing PT4A to control. The primary biological outcome is one-year change in systolic blood pressure. The primary adherence outcome is the pill count adherence ratio. The primary implementation outcome is fidelity. Secondary outcomes are blood pressure control, self-reported adherence, and RE-AIM metrics. Aim 2 will evaluate potential mechanistic relationships between implementation measures and outcomes. Sub Aim 2.1 will evaluate if trust in the health system and patient activation mediate the relationship between PT4A and the outcomes. Aim 3 will consist of cost-effectiveness, budget impact, and qualitative analyses to help inform adaptation of PT4A to other settings. The research will be conducted by a transdisciplinary team with diverse and complementary expertise. The investigators intend to add to existing knowledge of innovative and scalable strategies to improve medication adherence for global hypertension control.

Interventions

Door-to-door peer delivery of medications within patients' communities will be implemented.

The HIT platform provides: 1) tailored counseling strategies through decision support; 2) teleconsultation support for clinician-peer-patient interactions; 3) medication refill tracking to enhance accountability of the peer delivery process; and 4) analytics to improve medication supply chain by generating patient-level drug consumption data.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Adult participants enrolled in AMPATH's CDM Program with uncontrolled hypertension (SBP ≥ 140 or diastolic BP (DBP) ≥ 90)

Exclusion criteria

* hypertensive emergency requiring immediate medical attention, * terminal illness, and * inability to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in SBP from Baseline to Month 12Baseline, Month 12
Pill Count Adherence Ratio (PCAR) at Month 12Month 12PCAR is calculated as the percentage of pills taken over the previous month and is measured over a 30-day time period.
Number of Patient E-SignaturesUp to Month 12Measure of fidelity.
Number of Completed HIT FormsUp to Month 12Measure of fidelity.

Secondary

MeasureTime frameDescription
Mean Change in SBP from Baseline to Month 6Baseline, Month 6
Percentage of Participants with Controlled Blood Pressure (BP) at Month 6Month 6BP measured using automatic BP monitor.
Percentage of Participants with Controlled BP at Month 12Month 12BP measured using automatic BP monitor.

Countries

Kenya

Contacts

CONTACTRajesh Vedanthan
Rajesh.vedanthan@nyulangone.org1-646-501-3890
CONTACTJessica Gjonaj
Jessica.gjonaj@nyulangone.org1-646-501-3663
PRINCIPAL_INVESTIGATORRajesh Vedanthan

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026